長時間作用型可逆性避妊薬（LARC）のグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global Long-acting Reversible Contraceptives (LARCs) Market Insights, Forecast to 2028

• レポートコード：QY2207E09669 • 出版社/出版日：QYResearch / 2022年7月 • レポート形態：英文、PDF、117ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療機器

• 販売価格（消費税別）

Single User	￥735,000 (USD4,900)	▷ お問い合わせ
Multi User	￥1,102,500 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,470,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

新型コロナウイルス感染症のパンデミックにより、世界の長時間作用型可逆性避妊薬（LARC）の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に長時間作用型可逆性避妊薬（LARC）の世界市場のxxx％を占める「ホルモン性子宮内避妊器具」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「20〜24歳」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国の長時間作用型可逆性避妊薬（LARC）の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの長時間作用型可逆性避妊薬（LARC）市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの長時間作用型可逆性避妊薬（LARC）市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 長時間作用型可逆性避妊薬（LARC）のグローバル主要メーカーには、Bayer、Merck、Cooper Companies、AbbVie Allergan、Yantai JiShengYaoXie、H & J Medical、HRA Pharma、Pregna、ASPIVIX、Shanghai Dahua Pharmaceuticals、Williams Medical Supplies、Laboratoire 7 MED、Durbin、Laboratoire CCD、Prosan、OCONなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 長時間作用型可逆性避妊薬（LARC）市場は、種類と用途によって区分されます。世界の長時間作用型可逆性避妊薬（LARC）市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 ホルモン性子宮内避妊器具、銅子宮内避妊器具、避妊用インプラント、その他 【用途別セグメント】 20〜24歳、25〜34歳、35〜44歳、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 長時間作用型可逆性避妊薬（LARC）製品概要 - 種類別市場（ホルモン性子宮内避妊器具、銅子宮内避妊器具、避妊用インプラント、その他） - 用途別市場（20〜24歳、25〜34歳、35〜44歳、その他） - 調査の目的 ・エグゼクティブサマリー - 世界の長時間作用型可逆性避妊薬（LARC）販売量予測2017-2028 - 世界の長時間作用型可逆性避妊薬（LARC）売上予測2017-2028 - 長時間作用型可逆性避妊薬（LARC）の地域別販売量 - 長時間作用型可逆性避妊薬（LARC）の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別長時間作用型可逆性避妊薬（LARC）販売量 - 主要メーカー別長時間作用型可逆性避妊薬（LARC）売上 - 主要メーカー別長時間作用型可逆性避妊薬（LARC）価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（ホルモン性子宮内避妊器具、銅子宮内避妊器具、避妊用インプラント、その他） - 長時間作用型可逆性避妊薬（LARC）の種類別販売量 - 長時間作用型可逆性避妊薬（LARC）の種類別売上 - 長時間作用型可逆性避妊薬（LARC）の種類別価格 ・用途別市場規模（20〜24歳、25〜34歳、35〜44歳、その他） - 長時間作用型可逆性避妊薬（LARC）の用途別販売量 - 長時間作用型可逆性避妊薬（LARC）の用途別売上 - 長時間作用型可逆性避妊薬（LARC）の用途別価格 ・北米市場 - 北米の長時間作用型可逆性避妊薬（LARC）市場規模（種類別、用途別） - 主要国別の長時間作用型可逆性避妊薬（LARC）市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの長時間作用型可逆性避妊薬（LARC）市場規模（種類別、用途別） - 主要国別の長時間作用型可逆性避妊薬（LARC）市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の長時間作用型可逆性避妊薬（LARC）市場規模（種類別、用途別） - 主要国別の長時間作用型可逆性避妊薬（LARC）市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の長時間作用型可逆性避妊薬（LARC）市場規模（種類別、用途別） - 主要国別の長時間作用型可逆性避妊薬（LARC）市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの長時間作用型可逆性避妊薬（LARC）市場規模（種類別、用途別） - 主要国別の長時間作用型可逆性避妊薬（LARC）市場規模（トルコ、サウジアラビア） ・企業情報 Bayer、Merck、Cooper Companies、AbbVie Allergan、Yantai JiShengYaoXie、H & J Medical、HRA Pharma、Pregna、ASPIVIX、Shanghai Dahua Pharmaceuticals、Williams Medical Supplies、Laboratoire 7 MED、Durbin、Laboratoire CCD、Prosan、OCON ・産業チェーン及び販売チャネル分析 - 長時間作用型可逆性避妊薬（LARC）の産業チェーン分析 - 長時間作用型可逆性避妊薬（LARC）の原材料 - 長時間作用型可逆性避妊薬（LARC）の生産プロセス - 長時間作用型可逆性避妊薬（LARC）の販売及びマーケティング - 長時間作用型可逆性避妊薬（LARC）の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 長時間作用型可逆性避妊薬（LARC）の産業動向 - 長時間作用型可逆性避妊薬（LARC）のマーケットドライバー - 長時間作用型可逆性避妊薬（LARC）の課題 - 長時間作用型可逆性避妊薬（LARC）の阻害要因 ・主な調査結果

Market Analysis and Insights: Global Long-acting Reversible Contraceptives (LARCs) Market
Due to the COVID-19 pandemic, the global Long-acting Reversible Contraceptives (LARCs) market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Hormonal Intrauterine Devices accounting for % of the Long-acting Reversible Contraceptives (LARCs) global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Age 20-24 segment is altered to an % CAGR throughout this forecast period.
China Long-acting Reversible Contraceptives (LARCs) market size is valued at US$ million in 2021, while the US and Europe Long-acting Reversible Contraceptives (LARCs) are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Long-acting Reversible Contraceptives (LARCs) landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Long-acting Reversible Contraceptives (LARCs) include Bayer, Merck, Cooper Companies, AbbVie Allergan, Yantai JiShengYaoXie, H & J Medical, HRA Pharma, Pregna and ASPIVIX, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Long-acting Reversible Contraceptives (LARCs) Scope and Segment
Long-acting Reversible Contraceptives (LARCs) market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Long-acting Reversible Contraceptives (LARCs) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Hormonal Intrauterine Devices
Copper Intrauterine Devices
Contraceptive Implants
Others
Segment by Application
Age 20-24
Age 25-34
Age 35-44
Others
By Company
Bayer
Merck
Cooper Companies
AbbVie Allergan
Yantai JiShengYaoXie
H & J Medical
HRA Pharma
Pregna
ASPIVIX
Shanghai Dahua Pharmaceuticals
Williams Medical Supplies
Laboratoire 7 MED
Durbin
Laboratoire CCD
Prosan
OCON
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

---

1 Study Coverage
1.1 Long-acting Reversible Contraceptives (LARCs) Product Introduction
1.2 Market by Type
1.2.1 Global Long-acting Reversible Contraceptives (LARCs) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Hormonal Intrauterine Devices
1.2.3 Copper Intrauterine Devices
1.2.4 Contraceptive Implants
1.2.5 Others
1.3 Market by Application
1.3.1 Global Long-acting Reversible Contraceptives (LARCs) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Age 20-24
1.3.3 Age 25-34
1.3.4 Age 35-44
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Long-acting Reversible Contraceptives (LARCs) Sales Estimates and Forecasts 2017-2028
2.2 Global Long-acting Reversible Contraceptives (LARCs) Revenue Estimates and Forecasts 2017-2028
2.3 Global Long-acting Reversible Contraceptives (LARCs) Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Long-acting Reversible Contraceptives (LARCs) Sales by Region
2.4.1 Global Long-acting Reversible Contraceptives (LARCs) Sales by Region (2017-2022)
2.4.2 Global Sales Long-acting Reversible Contraceptives (LARCs) by Region (2023-2028)
2.5 Global Long-acting Reversible Contraceptives (LARCs) Revenue by Region
2.5.1 Global Long-acting Reversible Contraceptives (LARCs) Revenue by Region (2017-2022)
2.5.2 Global Long-acting Reversible Contraceptives (LARCs) Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Long-acting Reversible Contraceptives (LARCs) Sales by Manufacturers
3.1.1 Global Top Long-acting Reversible Contraceptives (LARCs) Manufacturers by Sales (2017-2022)
3.1.2 Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Long-acting Reversible Contraceptives (LARCs) in 2021
3.2 Global Long-acting Reversible Contraceptives (LARCs) Revenue by Manufacturers
3.2.1 Global Long-acting Reversible Contraceptives (LARCs) Revenue by Manufacturers (2017-2022)
3.2.2 Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Long-acting Reversible Contraceptives (LARCs) Revenue in 2021
3.3 Global Long-acting Reversible Contraceptives (LARCs) Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Long-acting Reversible Contraceptives (LARCs) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Long-acting Reversible Contraceptives (LARCs) Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Long-acting Reversible Contraceptives (LARCs) Sales by Type
4.1.1 Global Long-acting Reversible Contraceptives (LARCs) Historical Sales by Type (2017-2022)
4.1.2 Global Long-acting Reversible Contraceptives (LARCs) Forecasted Sales by Type (2023-2028)
4.1.3 Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Type (2017-2028)
4.2 Global Long-acting Reversible Contraceptives (LARCs) Revenue by Type
4.2.1 Global Long-acting Reversible Contraceptives (LARCs) Historical Revenue by Type (2017-2022)
4.2.2 Global Long-acting Reversible Contraceptives (LARCs) Forecasted Revenue by Type (2023-2028)
4.2.3 Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Type (2017-2028)
4.3 Global Long-acting Reversible Contraceptives (LARCs) Price by Type
4.3.1 Global Long-acting Reversible Contraceptives (LARCs) Price by Type (2017-2022)
4.3.2 Global Long-acting Reversible Contraceptives (LARCs) Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Long-acting Reversible Contraceptives (LARCs) Sales by Application
5.1.1 Global Long-acting Reversible Contraceptives (LARCs) Historical Sales by Application (2017-2022)
5.1.2 Global Long-acting Reversible Contraceptives (LARCs) Forecasted Sales by Application (2023-2028)
5.1.3 Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Application (2017-2028)
5.2 Global Long-acting Reversible Contraceptives (LARCs) Revenue by Application
5.2.1 Global Long-acting Reversible Contraceptives (LARCs) Historical Revenue by Application (2017-2022)
5.2.2 Global Long-acting Reversible Contraceptives (LARCs) Forecasted Revenue by Application (2023-2028)
5.2.3 Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Application (2017-2028)
5.3 Global Long-acting Reversible Contraceptives (LARCs) Price by Application
5.3.1 Global Long-acting Reversible Contraceptives (LARCs) Price by Application (2017-2022)
5.3.2 Global Long-acting Reversible Contraceptives (LARCs) Price Forecast by Application (2023-2028)
6 North America
6.1 North America Long-acting Reversible Contraceptives (LARCs) Market Size by Type
6.1.1 North America Long-acting Reversible Contraceptives (LARCs) Sales by Type (2017-2028)
6.1.2 North America Long-acting Reversible Contraceptives (LARCs) Revenue by Type (2017-2028)
6.2 North America Long-acting Reversible Contraceptives (LARCs) Market Size by Application
6.2.1 North America Long-acting Reversible Contraceptives (LARCs) Sales by Application (2017-2028)
6.2.2 North America Long-acting Reversible Contraceptives (LARCs) Revenue by Application (2017-2028)
6.3 North America Long-acting Reversible Contraceptives (LARCs) Market Size by Country
6.3.1 North America Long-acting Reversible Contraceptives (LARCs) Sales by Country (2017-2028)
6.3.2 North America Long-acting Reversible Contraceptives (LARCs) Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Long-acting Reversible Contraceptives (LARCs) Market Size by Type
7.1.1 Europe Long-acting Reversible Contraceptives (LARCs) Sales by Type (2017-2028)
7.1.2 Europe Long-acting Reversible Contraceptives (LARCs) Revenue by Type (2017-2028)
7.2 Europe Long-acting Reversible Contraceptives (LARCs) Market Size by Application
7.2.1 Europe Long-acting Reversible Contraceptives (LARCs) Sales by Application (2017-2028)
7.2.2 Europe Long-acting Reversible Contraceptives (LARCs) Revenue by Application (2017-2028)
7.3 Europe Long-acting Reversible Contraceptives (LARCs) Market Size by Country
7.3.1 Europe Long-acting Reversible Contraceptives (LARCs) Sales by Country (2017-2028)
7.3.2 Europe Long-acting Reversible Contraceptives (LARCs) Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Long-acting Reversible Contraceptives (LARCs) Market Size by Type
8.1.1 Asia Pacific Long-acting Reversible Contraceptives (LARCs) Sales by Type (2017-2028)
8.1.2 Asia Pacific Long-acting Reversible Contraceptives (LARCs) Revenue by Type (2017-2028)
8.2 Asia Pacific Long-acting Reversible Contraceptives (LARCs) Market Size by Application
8.2.1 Asia Pacific Long-acting Reversible Contraceptives (LARCs) Sales by Application (2017-2028)
8.2.2 Asia Pacific Long-acting Reversible Contraceptives (LARCs) Revenue by Application (2017-2028)
8.3 Asia Pacific Long-acting Reversible Contraceptives (LARCs) Market Size by Region
8.3.1 Asia Pacific Long-acting Reversible Contraceptives (LARCs) Sales by Region (2017-2028)
8.3.2 Asia Pacific Long-acting Reversible Contraceptives (LARCs) Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Long-acting Reversible Contraceptives (LARCs) Market Size by Type
9.1.1 Latin America Long-acting Reversible Contraceptives (LARCs) Sales by Type (2017-2028)
9.1.2 Latin America Long-acting Reversible Contraceptives (LARCs) Revenue by Type (2017-2028)
9.2 Latin America Long-acting Reversible Contraceptives (LARCs) Market Size by Application
9.2.1 Latin America Long-acting Reversible Contraceptives (LARCs) Sales by Application (2017-2028)
9.2.2 Latin America Long-acting Reversible Contraceptives (LARCs) Revenue by Application (2017-2028)
9.3 Latin America Long-acting Reversible Contraceptives (LARCs) Market Size by Country
9.3.1 Latin America Long-acting Reversible Contraceptives (LARCs) Sales by Country (2017-2028)
9.3.2 Latin America Long-acting Reversible Contraceptives (LARCs) Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Market Size by Type
10.1.1 Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Sales by Type (2017-2028)
10.1.2 Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Revenue by Type (2017-2028)
10.2 Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Market Size by Application
10.2.1 Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Sales by Application (2017-2028)
10.2.2 Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Revenue by Application (2017-2028)
10.3 Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Market Size by Country
10.3.1 Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Sales by Country (2017-2028)
10.3.2 Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Bayer
11.1.1 Bayer Corporation Information
11.1.2 Bayer Overview
11.1.3 Bayer Long-acting Reversible Contraceptives (LARCs) Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Bayer Long-acting Reversible Contraceptives (LARCs) Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Bayer Recent Developments
11.2 Merck
11.2.1 Merck Corporation Information
11.2.2 Merck Overview
11.2.3 Merck Long-acting Reversible Contraceptives (LARCs) Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Merck Long-acting Reversible Contraceptives (LARCs) Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Merck Recent Developments
11.3 Cooper Companies
11.3.1 Cooper Companies Corporation Information
11.3.2 Cooper Companies Overview
11.3.3 Cooper Companies Long-acting Reversible Contraceptives (LARCs) Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Cooper Companies Long-acting Reversible Contraceptives (LARCs) Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Cooper Companies Recent Developments
11.4 AbbVie Allergan
11.4.1 AbbVie Allergan Corporation Information
11.4.2 AbbVie Allergan Overview
11.4.3 AbbVie Allergan Long-acting Reversible Contraceptives (LARCs) Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 AbbVie Allergan Long-acting Reversible Contraceptives (LARCs) Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 AbbVie Allergan Recent Developments
11.5 Yantai JiShengYaoXie
11.5.1 Yantai JiShengYaoXie Corporation Information
11.5.2 Yantai JiShengYaoXie Overview
11.5.3 Yantai JiShengYaoXie Long-acting Reversible Contraceptives (LARCs) Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Yantai JiShengYaoXie Long-acting Reversible Contraceptives (LARCs) Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Yantai JiShengYaoXie Recent Developments
11.6 H & J Medical
11.6.1 H & J Medical Corporation Information
11.6.2 H & J Medical Overview
11.6.3 H & J Medical Long-acting Reversible Contraceptives (LARCs) Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 H & J Medical Long-acting Reversible Contraceptives (LARCs) Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 H & J Medical Recent Developments
11.7 HRA Pharma
11.7.1 HRA Pharma Corporation Information
11.7.2 HRA Pharma Overview
11.7.3 HRA Pharma Long-acting Reversible Contraceptives (LARCs) Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 HRA Pharma Long-acting Reversible Contraceptives (LARCs) Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 HRA Pharma Recent Developments
11.8 Pregna
11.8.1 Pregna Corporation Information
11.8.2 Pregna Overview
11.8.3 Pregna Long-acting Reversible Contraceptives (LARCs) Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Pregna Long-acting Reversible Contraceptives (LARCs) Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Pregna Recent Developments
11.9 ASPIVIX
11.9.1 ASPIVIX Corporation Information
11.9.2 ASPIVIX Overview
11.9.3 ASPIVIX Long-acting Reversible Contraceptives (LARCs) Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 ASPIVIX Long-acting Reversible Contraceptives (LARCs) Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 ASPIVIX Recent Developments
11.10 Shanghai Dahua Pharmaceuticals
11.10.1 Shanghai Dahua Pharmaceuticals Corporation Information
11.10.2 Shanghai Dahua Pharmaceuticals Overview
11.10.3 Shanghai Dahua Pharmaceuticals Long-acting Reversible Contraceptives (LARCs) Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Shanghai Dahua Pharmaceuticals Long-acting Reversible Contraceptives (LARCs) Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Shanghai Dahua Pharmaceuticals Recent Developments
11.11 Williams Medical Supplies
11.11.1 Williams Medical Supplies Corporation Information
11.11.2 Williams Medical Supplies Overview
11.11.3 Williams Medical Supplies Long-acting Reversible Contraceptives (LARCs) Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Williams Medical Supplies Long-acting Reversible Contraceptives (LARCs) Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Williams Medical Supplies Recent Developments
11.12 Laboratoire 7 MED
11.12.1 Laboratoire 7 MED Corporation Information
11.12.2 Laboratoire 7 MED Overview
11.12.3 Laboratoire 7 MED Long-acting Reversible Contraceptives (LARCs) Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Laboratoire 7 MED Long-acting Reversible Contraceptives (LARCs) Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Laboratoire 7 MED Recent Developments
11.13 Durbin
11.13.1 Durbin Corporation Information
11.13.2 Durbin Overview
11.13.3 Durbin Long-acting Reversible Contraceptives (LARCs) Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Durbin Long-acting Reversible Contraceptives (LARCs) Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Durbin Recent Developments
11.14 Laboratoire CCD
11.14.1 Laboratoire CCD Corporation Information
11.14.2 Laboratoire CCD Overview
11.14.3 Laboratoire CCD Long-acting Reversible Contraceptives (LARCs) Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Laboratoire CCD Long-acting Reversible Contraceptives (LARCs) Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Laboratoire CCD Recent Developments
11.15 Prosan
11.15.1 Prosan Corporation Information
11.15.2 Prosan Overview
11.15.3 Prosan Long-acting Reversible Contraceptives (LARCs) Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Prosan Long-acting Reversible Contraceptives (LARCs) Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Prosan Recent Developments
11.16 OCON
11.16.1 OCON Corporation Information
11.16.2 OCON Overview
11.16.3 OCON Long-acting Reversible Contraceptives (LARCs) Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 OCON Long-acting Reversible Contraceptives (LARCs) Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 OCON Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Long-acting Reversible Contraceptives (LARCs) Industry Chain Analysis
12.2 Long-acting Reversible Contraceptives (LARCs) Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Long-acting Reversible Contraceptives (LARCs) Production Mode & Process
12.4 Long-acting Reversible Contraceptives (LARCs) Sales and Marketing
12.4.1 Long-acting Reversible Contraceptives (LARCs) Sales Channels
12.4.2 Long-acting Reversible Contraceptives (LARCs) Distributors
12.5 Long-acting Reversible Contraceptives (LARCs) Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Long-acting Reversible Contraceptives (LARCs) Industry Trends
13.2 Long-acting Reversible Contraceptives (LARCs) Market Drivers
13.3 Long-acting Reversible Contraceptives (LARCs) Market Challenges
13.4 Long-acting Reversible Contraceptives (LARCs) Market Restraints
14 Key Findings in The Global Long-acting Reversible Contraceptives (LARCs) Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Long-acting Reversible Contraceptives (LARCs) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Hormonal Intrauterine Devices
Table 3. Major Manufacturers of Copper Intrauterine Devices
Table 4. Major Manufacturers of Contraceptive Implants
Table 5. Major Manufacturers of Others
Table 6. Global Long-acting Reversible Contraceptives (LARCs) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Long-acting Reversible Contraceptives (LARCs) Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 8. Global Long-acting Reversible Contraceptives (LARCs) Sales by Region (2017-2022) & (K Units)
Table 9. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Region (2017-2022)
Table 10. Global Long-acting Reversible Contraceptives (LARCs) Sales by Region (2023-2028) & (K Units)
Table 11. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Region (2023-2028)
Table 12. Global Long-acting Reversible Contraceptives (LARCs) Revenue by Region (2017-2022) & (US$ Million)
Table 13. Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Region (2017-2022)
Table 14. Global Long-acting Reversible Contraceptives (LARCs) Revenue by Region (2023-2028) & (US$ Million)
Table 15. Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Region (2023-2028)
Table 16. Global Long-acting Reversible Contraceptives (LARCs) Sales by Manufacturers (2017-2022) & (K Units)
Table 17. Global Long-acting Reversible Contraceptives (LARCs) Sales Share by Manufacturers (2017-2022)
Table 18. Global Long-acting Reversible Contraceptives (LARCs) Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 19. Global Long-acting Reversible Contraceptives (LARCs) Revenue Share by Manufacturers (2017-2022)
Table 20. Long-acting Reversible Contraceptives (LARCs) Price by Manufacturers (2017-2022) &(US$/Unit)
Table 21. Global Long-acting Reversible Contraceptives (LARCs) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Long-acting Reversible Contraceptives (LARCs) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Long-acting Reversible Contraceptives (LARCs) as of 2021)
Table 23. Long-acting Reversible Contraceptives (LARCs) Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Long-acting Reversible Contraceptives (LARCs) Product Offered
Table 25. Date of Manufacturers Enter into Long-acting Reversible Contraceptives (LARCs) Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Long-acting Reversible Contraceptives (LARCs) Sales by Type (2017-2022) & (K Units)
Table 28. Global Long-acting Reversible Contraceptives (LARCs) Sales by Type (2023-2028) & (K Units)
Table 29. Global Long-acting Reversible Contraceptives (LARCs) Sales Share by Type (2017-2022)
Table 30. Global Long-acting Reversible Contraceptives (LARCs) Sales Share by Type (2023-2028)
Table 31. Global Long-acting Reversible Contraceptives (LARCs) Revenue by Type (2017-2022) & (US$ Million)
Table 32. Global Long-acting Reversible Contraceptives (LARCs) Revenue by Type (2023-2028) & (US$ Million)
Table 33. Global Long-acting Reversible Contraceptives (LARCs) Revenue Share by Type (2017-2022)
Table 34. Global Long-acting Reversible Contraceptives (LARCs) Revenue Share by Type (2023-2028)
Table 35. Long-acting Reversible Contraceptives (LARCs) Price by Type (2017-2022) & (US$/Unit)
Table 36. Global Long-acting Reversible Contraceptives (LARCs) Price Forecast by Type (2023-2028) & (US$/Unit)
Table 37. Global Long-acting Reversible Contraceptives (LARCs) Sales by Application (2017-2022) & (K Units)
Table 38. Global Long-acting Reversible Contraceptives (LARCs) Sales by Application (2023-2028) & (K Units)
Table 39. Global Long-acting Reversible Contraceptives (LARCs) Sales Share by Application (2017-2022)
Table 40. Global Long-acting Reversible Contraceptives (LARCs) Sales Share by Application (2023-2028)
Table 41. Global Long-acting Reversible Contraceptives (LARCs) Revenue by Application (2017-2022) & (US$ Million)
Table 42. Global Long-acting Reversible Contraceptives (LARCs) Revenue by Application (2023-2028) & (US$ Million)
Table 43. Global Long-acting Reversible Contraceptives (LARCs) Revenue Share by Application (2017-2022)
Table 44. Global Long-acting Reversible Contraceptives (LARCs) Revenue Share by Application (2023-2028)
Table 45. Long-acting Reversible Contraceptives (LARCs) Price by Application (2017-2022) & (US$/Unit)
Table 46. Global Long-acting Reversible Contraceptives (LARCs) Price Forecast by Application (2023-2028) & (US$/Unit)
Table 47. North America Long-acting Reversible Contraceptives (LARCs) Sales by Type (2017-2022) & (K Units)
Table 48. North America Long-acting Reversible Contraceptives (LARCs) Sales by Type (2023-2028) & (K Units)
Table 49. North America Long-acting Reversible Contraceptives (LARCs) Revenue by Type (2017-2022) & (US$ Million)
Table 50. North America Long-acting Reversible Contraceptives (LARCs) Revenue by Type (2023-2028) & (US$ Million)
Table 51. North America Long-acting Reversible Contraceptives (LARCs) Sales by Application (2017-2022) & (K Units)
Table 52. North America Long-acting Reversible Contraceptives (LARCs) Sales by Application (2023-2028) & (K Units)
Table 53. North America Long-acting Reversible Contraceptives (LARCs) Revenue by Application (2017-2022) & (US$ Million)
Table 54. North America Long-acting Reversible Contraceptives (LARCs) Revenue by Application (2023-2028) & (US$ Million)
Table 55. North America Long-acting Reversible Contraceptives (LARCs) Sales by Country (2017-2022) & (K Units)
Table 56. North America Long-acting Reversible Contraceptives (LARCs) Sales by Country (2023-2028) & (K Units)
Table 57. North America Long-acting Reversible Contraceptives (LARCs) Revenue by Country (2017-2022) & (US$ Million)
Table 58. North America Long-acting Reversible Contraceptives (LARCs) Revenue by Country (2023-2028) & (US$ Million)
Table 59. Europe Long-acting Reversible Contraceptives (LARCs) Sales by Type (2017-2022) & (K Units)
Table 60. Europe Long-acting Reversible Contraceptives (LARCs) Sales by Type (2023-2028) & (K Units)
Table 61. Europe Long-acting Reversible Contraceptives (LARCs) Revenue by Type (2017-2022) & (US$ Million)
Table 62. Europe Long-acting Reversible Contraceptives (LARCs) Revenue by Type (2023-2028) & (US$ Million)
Table 63. Europe Long-acting Reversible Contraceptives (LARCs) Sales by Application (2017-2022) & (K Units)
Table 64. Europe Long-acting Reversible Contraceptives (LARCs) Sales by Application (2023-2028) & (K Units)
Table 65. Europe Long-acting Reversible Contraceptives (LARCs) Revenue by Application (2017-2022) & (US$ Million)
Table 66. Europe Long-acting Reversible Contraceptives (LARCs) Revenue by Application (2023-2028) & (US$ Million)
Table 67. Europe Long-acting Reversible Contraceptives (LARCs) Sales by Country (2017-2022) & (K Units)
Table 68. Europe Long-acting Reversible Contraceptives (LARCs) Sales by Country (2023-2028) & (K Units)
Table 69. Europe Long-acting Reversible Contraceptives (LARCs) Revenue by Country (2017-2022) & (US$ Million)
Table 70. Europe Long-acting Reversible Contraceptives (LARCs) Revenue by Country (2023-2028) & (US$ Million)
Table 71. Asia Pacific Long-acting Reversible Contraceptives (LARCs) Sales by Type (2017-2022) & (K Units)
Table 72. Asia Pacific Long-acting Reversible Contraceptives (LARCs) Sales by Type (2023-2028) & (K Units)
Table 73. Asia Pacific Long-acting Reversible Contraceptives (LARCs) Revenue by Type (2017-2022) & (US$ Million)
Table 74. Asia Pacific Long-acting Reversible Contraceptives (LARCs) Revenue by Type (2023-2028) & (US$ Million)
Table 75. Asia Pacific Long-acting Reversible Contraceptives (LARCs) Sales by Application (2017-2022) & (K Units)
Table 76. Asia Pacific Long-acting Reversible Contraceptives (LARCs) Sales by Application (2023-2028) & (K Units)
Table 77. Asia Pacific Long-acting Reversible Contraceptives (LARCs) Revenue by Application (2017-2022) & (US$ Million)
Table 78. Asia Pacific Long-acting Reversible Contraceptives (LARCs) Revenue by Application (2023-2028) & (US$ Million)
Table 79. Asia Pacific Long-acting Reversible Contraceptives (LARCs) Sales by Region (2017-2022) & (K Units)
Table 80. Asia Pacific Long-acting Reversible Contraceptives (LARCs) Sales by Region (2023-2028) & (K Units)
Table 81. Asia Pacific Long-acting Reversible Contraceptives (LARCs) Revenue by Region (2017-2022) & (US$ Million)
Table 82. Asia Pacific Long-acting Reversible Contraceptives (LARCs) Revenue by Region (2023-2028) & (US$ Million)
Table 83. Latin America Long-acting Reversible Contraceptives (LARCs) Sales by Type (2017-2022) & (K Units)
Table 84. Latin America Long-acting Reversible Contraceptives (LARCs) Sales by Type (2023-2028) & (K Units)
Table 85. Latin America Long-acting Reversible Contraceptives (LARCs) Revenue by Type (2017-2022) & (US$ Million)
Table 86. Latin America Long-acting Reversible Contraceptives (LARCs) Revenue by Type (2023-2028) & (US$ Million)
Table 87. Latin America Long-acting Reversible Contraceptives (LARCs) Sales by Application (2017-2022) & (K Units)
Table 88. Latin America Long-acting Reversible Contraceptives (LARCs) Sales by Application (2023-2028) & (K Units)
Table 89. Latin America Long-acting Reversible Contraceptives (LARCs) Revenue by Application (2017-2022) & (US$ Million)
Table 90. Latin America Long-acting Reversible Contraceptives (LARCs) Revenue by Application (2023-2028) & (US$ Million)
Table 91. Latin America Long-acting Reversible Contraceptives (LARCs) Sales by Country (2017-2022) & (K Units)
Table 92. Latin America Long-acting Reversible Contraceptives (LARCs) Sales by Country (2023-2028) & (K Units)
Table 93. Latin America Long-acting Reversible Contraceptives (LARCs) Revenue by Country (2017-2022) & (US$ Million)
Table 94. Latin America Long-acting Reversible Contraceptives (LARCs) Revenue by Country (2023-2028) & (US$ Million)
Table 95. Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Sales by Type (2017-2022) & (K Units)
Table 96. Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Sales by Type (2023-2028) & (K Units)
Table 97. Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Revenue by Type (2017-2022) & (US$ Million)
Table 98. Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Revenue by Type (2023-2028) & (US$ Million)
Table 99. Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Sales by Application (2017-2022) & (K Units)
Table 100. Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Sales by Application (2023-2028) & (K Units)
Table 101. Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Revenue by Application (2017-2022) & (US$ Million)
Table 102. Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Revenue by Application (2023-2028) & (US$ Million)
Table 103. Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Sales by Country (2017-2022) & (K Units)
Table 104. Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Sales by Country (2023-2028) & (K Units)
Table 105. Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Revenue by Country (2017-2022) & (US$ Million)
Table 106. Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Revenue by Country (2023-2028) & (US$ Million)
Table 107. Bayer Corporation Information
Table 108. Bayer Description and Major Businesses
Table 109. Bayer Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 110. Bayer Long-acting Reversible Contraceptives (LARCs) Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Bayer Recent Developments
Table 112. Merck Corporation Information
Table 113. Merck Description and Major Businesses
Table 114. Merck Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 115. Merck Long-acting Reversible Contraceptives (LARCs) Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Merck Recent Developments
Table 117. Cooper Companies Corporation Information
Table 118. Cooper Companies Description and Major Businesses
Table 119. Cooper Companies Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 120. Cooper Companies Long-acting Reversible Contraceptives (LARCs) Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Cooper Companies Recent Developments
Table 122. AbbVie Allergan Corporation Information
Table 123. AbbVie Allergan Description and Major Businesses
Table 124. AbbVie Allergan Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 125. AbbVie Allergan Long-acting Reversible Contraceptives (LARCs) Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. AbbVie Allergan Recent Developments
Table 127. Yantai JiShengYaoXie Corporation Information
Table 128. Yantai JiShengYaoXie Description and Major Businesses
Table 129. Yantai JiShengYaoXie Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 130. Yantai JiShengYaoXie Long-acting Reversible Contraceptives (LARCs) Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Yantai JiShengYaoXie Recent Developments
Table 132. H & J Medical Corporation Information
Table 133. H & J Medical Description and Major Businesses
Table 134. H & J Medical Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 135. H & J Medical Long-acting Reversible Contraceptives (LARCs) Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. H & J Medical Recent Developments
Table 137. HRA Pharma Corporation Information
Table 138. HRA Pharma Description and Major Businesses
Table 139. HRA Pharma Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 140. HRA Pharma Long-acting Reversible Contraceptives (LARCs) Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. HRA Pharma Recent Developments
Table 142. Pregna Corporation Information
Table 143. Pregna Description and Major Businesses
Table 144. Pregna Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 145. Pregna Long-acting Reversible Contraceptives (LARCs) Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Pregna Recent Developments
Table 147. ASPIVIX Corporation Information
Table 148. ASPIVIX Description and Major Businesses
Table 149. ASPIVIX Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 150. ASPIVIX Long-acting Reversible Contraceptives (LARCs) Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. ASPIVIX Recent Developments
Table 152. Shanghai Dahua Pharmaceuticals Corporation Information
Table 153. Shanghai Dahua Pharmaceuticals Description and Major Businesses
Table 154. Shanghai Dahua Pharmaceuticals Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 155. Shanghai Dahua Pharmaceuticals Long-acting Reversible Contraceptives (LARCs) Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Shanghai Dahua Pharmaceuticals Recent Developments
Table 157. Williams Medical Supplies Corporation Information
Table 158. Williams Medical Supplies Description and Major Businesses
Table 159. Williams Medical Supplies Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 160. Williams Medical Supplies Long-acting Reversible Contraceptives (LARCs) Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. Williams Medical Supplies Recent Developments
Table 162. Laboratoire 7 MED Corporation Information
Table 163. Laboratoire 7 MED Description and Major Businesses
Table 164. Laboratoire 7 MED Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 165. Laboratoire 7 MED Long-acting Reversible Contraceptives (LARCs) Product Model Numbers, Pictures, Descriptions and Specifications
Table 166. Laboratoire 7 MED Recent Developments
Table 167. Durbin Corporation Information
Table 168. Durbin Description and Major Businesses
Table 169. Durbin Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 170. Durbin Long-acting Reversible Contraceptives (LARCs) Product Model Numbers, Pictures, Descriptions and Specifications
Table 171. Durbin Recent Developments
Table 172. Laboratoire CCD Corporation Information
Table 173. Laboratoire CCD Description and Major Businesses
Table 174. Laboratoire CCD Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 175. Laboratoire CCD Long-acting Reversible Contraceptives (LARCs) Product Model Numbers, Pictures, Descriptions and Specifications
Table 176. Laboratoire CCD Recent Developments
Table 177. Prosan Corporation Information
Table 178. Prosan Description and Major Businesses
Table 179. Prosan Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 180. Prosan Long-acting Reversible Contraceptives (LARCs) Product Model Numbers, Pictures, Descriptions and Specifications
Table 181. Prosan Recent Developments
Table 182. OCON Corporation Information
Table 183. OCON Description and Major Businesses
Table 184. OCON Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 185. OCON Long-acting Reversible Contraceptives (LARCs) Product Model Numbers, Pictures, Descriptions and Specifications
Table 186. OCON Recent Developments
Table 187. Key Raw Materials Lists
Table 188. Raw Materials Key Suppliers Lists
Table 189. Long-acting Reversible Contraceptives (LARCs) Distributors List
Table 190. Long-acting Reversible Contraceptives (LARCs) Customers List
Table 191. Long-acting Reversible Contraceptives (LARCs) Market Trends
Table 192. Long-acting Reversible Contraceptives (LARCs) Market Drivers
Table 193. Long-acting Reversible Contraceptives (LARCs) Market Challenges
Table 194. Long-acting Reversible Contraceptives (LARCs) Market Restraints
Table 195. Research Programs/Design for This Report
Table 196. Key Data Information from Secondary Sources
Table 197. Key Data Information from Primary Sources
List of Figures
Figure 1. Long-acting Reversible Contraceptives (LARCs) Product Picture
Figure 3. Global Long-acting Reversible Contraceptives (LARCs) Market Share by Type in 2021 & 2028
Figure 3. Hormonal Intrauterine Devices Product Picture
Figure 4. Copper Intrauterine Devices Product Picture
Figure 5. Contraceptive Implants Product Picture
Figure 6. Others Product Picture
Figure 7. Global Long-acting Reversible Contraceptives (LARCs) Market Share by Application in 2021 & 2028
Figure 8. Age 20-24
Figure 9. Age 25-34
Figure 10. Age 35-44
Figure 11. Others
Figure 12. Long-acting Reversible Contraceptives (LARCs) Report Years Considered
Figure 13. Global Long-acting Reversible Contraceptives (LARCs) Sales 2017-2028 (K Units)
Figure 14. Global Long-acting Reversible Contraceptives (LARCs) Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 15. Global Long-acting Reversible Contraceptives (LARCs) Revenue 2017-2028 (US$ Million)
Figure 16. Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 17. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Region (2017-2022)
Figure 18. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Region (2023-2028)
Figure 19. North America Long-acting Reversible Contraceptives (LARCs) Sales YoY (2017-2028) & (K Units)
Figure 20. North America Long-acting Reversible Contraceptives (LARCs) Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Europe Long-acting Reversible Contraceptives (LARCs) Sales YoY (2017-2028) & (K Units)
Figure 22. Europe Long-acting Reversible Contraceptives (LARCs) Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Sales YoY (2017-2028) & (K Units)
Figure 24. Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Latin America Long-acting Reversible Contraceptives (LARCs) Sales YoY (2017-2028) & (K Units)
Figure 26. Latin America Long-acting Reversible Contraceptives (LARCs) Revenue YoY (2017-2028) & (US$ Million)
Figure 27. Middle East & Africa Long-acting Reversible Contraceptives (LARCs) Sales YoY (2017-2028) & (K Units)
Figure 28. Middle East & Africa Long-acting Reversible Contraceptives (LARCs) Revenue YoY (2017-2028) & (US$ Million)
Figure 29. The Long-acting Reversible Contraceptives (LARCs) Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 30. The Top 5 and 10 Largest Manufacturers of Long-acting Reversible Contraceptives (LARCs) in the World: Market Share by Long-acting Reversible Contraceptives (LARCs) Revenue in 2021
Figure 31. Global Long-acting Reversible Contraceptives (LARCs) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 32. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Type (2017-2028)
Figure 33. Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Type (2017-2028)
Figure 34. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Application (2017-2028)
Figure 35. Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Application (2017-2028)
Figure 36. North America Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Type (2017-2028)
Figure 37. North America Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Type (2017-2028)
Figure 38. North America Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Application (2017-2028)
Figure 39. North America Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Application (2017-2028)
Figure 40. North America Long-acting Reversible Contraceptives (LARCs) Sales Share by Country (2017-2028)
Figure 41. North America Long-acting Reversible Contraceptives (LARCs) Revenue Share by Country (2017-2028)
Figure 42. United States Long-acting Reversible Contraceptives (LARCs) Revenue (2017-2028) & (US$ Million)
Figure 43. Canada Long-acting Reversible Contraceptives (LARCs) Revenue (2017-2028) & (US$ Million)
Figure 44. Europe Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Type (2017-2028)
Figure 45. Europe Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Type (2017-2028)
Figure 46. Europe Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Application (2017-2028)
Figure 47. Europe Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Application (2017-2028)
Figure 48. Europe Long-acting Reversible Contraceptives (LARCs) Sales Share by Country (2017-2028)
Figure 49. Europe Long-acting Reversible Contraceptives (LARCs) Revenue Share by Country (2017-2028)
Figure 50. Germany Long-acting Reversible Contraceptives (LARCs) Revenue (2017-2028) & (US$ Million)
Figure 51. France Long-acting Reversible Contraceptives (LARCs) Revenue (2017-2028) & (US$ Million)
Figure 52. U.K. Long-acting Reversible Contraceptives (LARCs) Revenue (2017-2028) & (US$ Million)
Figure 53. Italy Long-acting Reversible Contraceptives (LARCs) Revenue (2017-2028) & (US$ Million)
Figure 54. Russia Long-acting Reversible Contraceptives (LARCs) Revenue (2017-2028) & (US$ Million)
Figure 55. Asia Pacific Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Type (2017-2028)
Figure 56. Asia Pacific Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Type (2017-2028)
Figure 57. Asia Pacific Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Application (2017-2028)
Figure 58. Asia Pacific Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Application (2017-2028)
Figure 59. Asia Pacific Long-acting Reversible Contraceptives (LARCs) Sales Share by Region (2017-2028)
Figure 60. Asia Pacific Long-acting Reversible Contraceptives (LARCs) Revenue Share by Region (2017-2028)
Figure 61. China Long-acting Reversible Contraceptives (LARCs) Revenue (2017-2028) & (US$ Million)
Figure 62. Japan Long-acting Reversible Contraceptives (LARCs) Revenue (2017-2028) & (US$ Million)
Figure 63. South Korea Long-acting Reversible Contraceptives (LARCs) Revenue (2017-2028) & (US$ Million)
Figure 64. India Long-acting Reversible Contraceptives (LARCs) Revenue (2017-2028) & (US$ Million)
Figure 65. Australia Long-acting Reversible Contraceptives (LARCs) Revenue (2017-2028) & (US$ Million)
Figure 66. China Taiwan Long-acting Reversible Contraceptives (LARCs) Revenue (2017-2028) & (US$ Million)
Figure 67. Indonesia Long-acting Reversible Contraceptives (LARCs) Revenue (2017-2028) & (US$ Million)
Figure 68. Thailand Long-acting Reversible Contraceptives (LARCs) Revenue (2017-2028) & (US$ Million)
Figure 69. Malaysia Long-acting Reversible Contraceptives (LARCs) Revenue (2017-2028) & (US$ Million)
Figure 70. Latin America Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Type (2017-2028)
Figure 71. Latin America Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Type (2017-2028)
Figure 72. Latin America Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Application (2017-2028)
Figure 73. Latin America Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Application (2017-2028)
Figure 74. Latin America Long-acting Reversible Contraceptives (LARCs) Sales Share by Country (2017-2028)
Figure 75. Latin America Long-acting Reversible Contraceptives (LARCs) Revenue Share by Country (2017-2028)
Figure 76. Mexico Long-acting Reversible Contraceptives (LARCs) Revenue (2017-2028) & (US$ Million)
Figure 77. Brazil Long-acting Reversible Contraceptives (LARCs) Revenue (2017-2028) & (US$ Million)
Figure 78. Argentina Long-acting Reversible Contraceptives (LARCs) Revenue (2017-2028) & (US$ Million)
Figure 79. Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Type (2017-2028)
Figure 80. Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Type (2017-2028)
Figure 81. Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Application (2017-2028)
Figure 82. Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Application (2017-2028)
Figure 83. Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Sales Share by Country (2017-2028)
Figure 84. Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Revenue Share by Country (2017-2028)
Figure 85. Turkey Long-acting Reversible Contraceptives (LARCs) Revenue (2017-2028) & (US$ Million)
Figure 86. Saudi Arabia Long-acting Reversible Contraceptives (LARCs) Revenue (2017-2028) & (US$ Million)
Figure 87. UAE Long-acting Reversible Contraceptives (LARCs) Revenue (2017-2028) & (US$ Million)
Figure 88. Long-acting Reversible Contraceptives (LARCs) Value Chain
Figure 89. Long-acting Reversible Contraceptives (LARCs) Production Process
Figure 90. Channels of Distribution
Figure 91. Distributors Profiles
Figure 92. Bottom-up and Top-down Approaches for This Report
Figure 93. Data Triangulation
Figure 94. Key Executives Interviewed

---